Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination
Identifieur interne : 001C28 ( Istex/Corpus ); précédent : 001C27; suivant : 001C29Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination
Auteurs : Francesca Galeotti ; Marco Massari ; Roberto D Lessandro ; Ettore Beghi ; Adriano Chi ; Giancarlo Logroscino ; Graziella Filippini ; Maria Donata Benedetti ; Maura Pugliatti ; Carmela Santuccio ; Roberto RaschettiSource :
- European Journal of Epidemiology [ 0393-2990 ] ; 2013.
Abstract
Abstract: Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.
Url:
DOI: 10.1007/s10654-013-9797-8
Links to Exploration step
ISTEX:7645AB1CD10843E7F28770CD56AFD76FCB026A53Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title><author><name sortKey="Galeotti, Francesca" sort="Galeotti, Francesca" uniqKey="Galeotti F" first="Francesca" last="Galeotti">Francesca Galeotti</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Massari, Marco" sort="Massari, Marco" uniqKey="Massari M" first="Marco" last="Massari">Marco Massari</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="D Lessandro, Roberto" sort="D Lessandro, Roberto" uniqKey="D Lessandro R" first="Roberto" last="D Lessandro">Roberto D Lessandro</name><affiliation><mods:affiliation>Neuroepidemiology Unit, I.R.C.C.S. Istituto delle Scienze Neurologiche, Bologna, Italy</mods:affiliation></affiliation></author><author><name sortKey="Beghi, Ettore" sort="Beghi, Ettore" uniqKey="Beghi E" first="Ettore" last="Beghi">Ettore Beghi</name><affiliation><mods:affiliation>Laboratory of Neurological Disorders, “Mario Negri” Institute for Pharmacological Research, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Chi, Adriano" sort="Chi, Adriano" uniqKey="Chi A" first="Adriano" last="Chi">Adriano Chi</name><affiliation><mods:affiliation>Department of Neuroscience, University of Turin, Turin, Italy</mods:affiliation></affiliation></author><author><name sortKey="Logroscino, Giancarlo" sort="Logroscino, Giancarlo" uniqKey="Logroscino G" first="Giancarlo" last="Logroscino">Giancarlo Logroscino</name><affiliation><mods:affiliation>Department of Neurology and Psychiatry, University of Bari, Bari, Italy</mods:affiliation></affiliation></author><author><name sortKey="Filippini, Graziella" sort="Filippini, Graziella" uniqKey="Filippini G" first="Graziella" last="Filippini">Graziella Filippini</name><affiliation><mods:affiliation>Neuroepidemiology Unit, I.R.C.C.S. Foundation, Carlo Besta Neurological Institute, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Benedetti, Maria Donata" sort="Benedetti, Maria Donata" uniqKey="Benedetti M" first="Maria Donata" last="Benedetti">Maria Donata Benedetti</name><affiliation><mods:affiliation>Department of Neurosciences, University Hospital, Verona, Italy</mods:affiliation></affiliation></author><author><name sortKey="Pugliatti, Maura" sort="Pugliatti, Maura" uniqKey="Pugliatti M" first="Maura" last="Pugliatti">Maura Pugliatti</name><affiliation><mods:affiliation>Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</mods:affiliation></affiliation></author><author><name sortKey="Santuccio, Carmela" sort="Santuccio, Carmela" uniqKey="Santuccio C" first="Carmela" last="Santuccio">Carmela Santuccio</name><affiliation><mods:affiliation>Italian Medicine Agency (AIFA), Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Raschetti, Roberto" sort="Raschetti, Roberto" uniqKey="Raschetti R" first="Roberto" last="Raschetti">Roberto Raschetti</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: roberto.raschetti@iss.it</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7645AB1CD10843E7F28770CD56AFD76FCB026A53</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1007/s10654-013-9797-8</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001C28</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C28</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title><author><name sortKey="Galeotti, Francesca" sort="Galeotti, Francesca" uniqKey="Galeotti F" first="Francesca" last="Galeotti">Francesca Galeotti</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Massari, Marco" sort="Massari, Marco" uniqKey="Massari M" first="Marco" last="Massari">Marco Massari</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="D Lessandro, Roberto" sort="D Lessandro, Roberto" uniqKey="D Lessandro R" first="Roberto" last="D Lessandro">Roberto D Lessandro</name><affiliation><mods:affiliation>Neuroepidemiology Unit, I.R.C.C.S. Istituto delle Scienze Neurologiche, Bologna, Italy</mods:affiliation></affiliation></author><author><name sortKey="Beghi, Ettore" sort="Beghi, Ettore" uniqKey="Beghi E" first="Ettore" last="Beghi">Ettore Beghi</name><affiliation><mods:affiliation>Laboratory of Neurological Disorders, “Mario Negri” Institute for Pharmacological Research, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Chi, Adriano" sort="Chi, Adriano" uniqKey="Chi A" first="Adriano" last="Chi">Adriano Chi</name><affiliation><mods:affiliation>Department of Neuroscience, University of Turin, Turin, Italy</mods:affiliation></affiliation></author><author><name sortKey="Logroscino, Giancarlo" sort="Logroscino, Giancarlo" uniqKey="Logroscino G" first="Giancarlo" last="Logroscino">Giancarlo Logroscino</name><affiliation><mods:affiliation>Department of Neurology and Psychiatry, University of Bari, Bari, Italy</mods:affiliation></affiliation></author><author><name sortKey="Filippini, Graziella" sort="Filippini, Graziella" uniqKey="Filippini G" first="Graziella" last="Filippini">Graziella Filippini</name><affiliation><mods:affiliation>Neuroepidemiology Unit, I.R.C.C.S. Foundation, Carlo Besta Neurological Institute, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Benedetti, Maria Donata" sort="Benedetti, Maria Donata" uniqKey="Benedetti M" first="Maria Donata" last="Benedetti">Maria Donata Benedetti</name><affiliation><mods:affiliation>Department of Neurosciences, University Hospital, Verona, Italy</mods:affiliation></affiliation></author><author><name sortKey="Pugliatti, Maura" sort="Pugliatti, Maura" uniqKey="Pugliatti M" first="Maura" last="Pugliatti">Maura Pugliatti</name><affiliation><mods:affiliation>Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</mods:affiliation></affiliation></author><author><name sortKey="Santuccio, Carmela" sort="Santuccio, Carmela" uniqKey="Santuccio C" first="Carmela" last="Santuccio">Carmela Santuccio</name><affiliation><mods:affiliation>Italian Medicine Agency (AIFA), Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Raschetti, Roberto" sort="Raschetti, Roberto" uniqKey="Raschetti R" first="Roberto" last="Raschetti">Roberto Raschetti</name><affiliation><mods:affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: roberto.raschetti@iss.it</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">European Journal of Epidemiology</title><title level="j" type="abbrev">Eur J Epidemiol</title><idno type="ISSN">0393-2990</idno><idno type="eISSN">1573-7284</idno><imprint><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer Netherlands</publisher><pubPlace>Dordrecht</pubPlace><date type="published" when="2013">2013</date><biblScope unit="vol" from="28" to="28">28</biblScope><biblScope unit="issue" from="5" to="5">5</biblScope><biblScope unit="page" from="433">433</biblScope><biblScope unit="page" to="444">444</biblScope></imprint><idno type="ISSN">0393-2990</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0393-2990</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.</div></front></TEI><istex><corpusName>springer-journals</corpusName><author><json:item><name>Francesca Galeotti</name><affiliations><json:string>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</json:string></affiliations></json:item><json:item><name>Marco Massari</name><affiliations><json:string>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</json:string></affiliations></json:item><json:item><name>Roberto D’Alessandro</name><affiliations><json:string>Neuroepidemiology Unit, I.R.C.C.S. Istituto delle Scienze Neurologiche, Bologna, Italy</json:string></affiliations></json:item><json:item><name>Ettore Beghi</name><affiliations><json:string>Laboratory of Neurological Disorders, “Mario Negri” Institute for Pharmacological Research, Milan, Italy</json:string></affiliations></json:item><json:item><name>Adriano Chiò</name><affiliations><json:string>Department of Neuroscience, University of Turin, Turin, Italy</json:string></affiliations></json:item><json:item><name>Giancarlo Logroscino</name><affiliations><json:string>Department of Neurology and Psychiatry, University of Bari, Bari, Italy</json:string></affiliations></json:item><json:item><name>Graziella Filippini</name><affiliations><json:string>Neuroepidemiology Unit, I.R.C.C.S. Foundation, Carlo Besta Neurological Institute, Milan, Italy</json:string></affiliations></json:item><json:item><name>Maria Donata Benedetti</name><affiliations><json:string>Department of Neurosciences, University Hospital, Verona, Italy</json:string></affiliations></json:item><json:item><name>Maura Pugliatti</name><affiliations><json:string>Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</json:string></affiliations></json:item><json:item><name>Carmela Santuccio</name><affiliations><json:string>Italian Medicine Agency (AIFA), Rome, Italy</json:string></affiliations></json:item><json:item><name>Roberto Raschetti</name><affiliations><json:string>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</json:string><json:string>E-mail: roberto.raschetti@iss.it</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Influenza vaccination</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Guillain-Barrè Syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Case–control study</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Self controlled case series</value></json:item></subject><articleId><json:string>9797</json:string><json:string>s10654-013-9797-8</json:string></articleId><arkIstex>ark:/67375/VQC-SWXQST3K-W</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>OriginalPaper</json:string></originalGenre><abstract>Abstract: Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.</abstract><qualityIndicators><refBibsNative>false</refBibsNative><abstractWordCount>214</abstractWordCount><abstractCharCount>1368</abstractCharCount><keywordCount>4</keywordCount><score>8.235</score><pdfWordCount>5885</pdfWordCount><pdfCharCount>42800</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>12</pdfPageCount><pdfPageSize>595.276 x 790.866 pts</pdfPageSize><pdfWordsPerPage>490</pdfWordsPerPage><pdfText>true</pdfText></qualityIndicators><title>Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title><corporate><json:item><name>The ITANG study group</name></json:item></corporate><genre><json:string>research-article</json:string></genre><host><title>European Journal of Epidemiology</title><language><json:string>unknown</json:string></language><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><issn><json:string>0393-2990</json:string></issn><eissn><json:string>1573-7284</json:string></eissn><journalId><json:string>10654</json:string></journalId><volume>28</volume><issue>5</issue><pages><first>433</first><last>444</last></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Medicine</value></json:item><json:item><value>Medicine & Public Health</value></json:item><json:item><value>Epidemiology</value></json:item><json:item><value>Public Health</value></json:item><json:item><value>Infectious Diseases</value></json:item><json:item><value>Cardiology</value></json:item><json:item><value>Oncology</value></json:item></subject></host><ark><json:string>ark:/67375/VQC-SWXQST3K-W</json:string></ark><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1007/s10654-013-9797-8</json:string></doi><id>7645AB1CD10843E7F28770CD56AFD76FCB026A53</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer Netherlands</publisher><pubPlace>Dordrecht</pubPlace><availability status="free"><p>Open Access</p><licence>The Author(s)</licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p></availability><date type="published" when="2013">2013</date></publicationStmt><notesStmt><note type="content-type" subtype="research-article" source="OriginalPaper" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-5WTPMB5N-F">journal</note></notesStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title><author><persName><forename type="first">Francesca</forename><surname>Galeotti</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">National Centre for Epidemiology, Surveillance and Health Promotion</orgName><orgName type="institution">National Institute of Health</orgName><address><settlement>Rome</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Marco</forename><surname>Massari</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">National Centre for Epidemiology, Surveillance and Health Promotion</orgName><orgName type="institution">National Institute of Health</orgName><address><settlement>Rome</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Roberto</forename><surname>D’Alessandro</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Neuroepidemiology Unit</orgName><orgName type="institution">I.R.C.C.S. Istituto delle Scienze Neurologiche</orgName><address><settlement>Bologna</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Ettore</forename><surname>Beghi</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Laboratory of Neurological Disorders</orgName><orgName type="institution">“Mario Negri” Institute for Pharmacological Research</orgName><address><settlement>Milan</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Adriano</forename><surname>Chiò</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Department of Neuroscience</orgName><orgName type="institution">University of Turin</orgName><address><settlement>Turin</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Giancarlo</forename><surname>Logroscino</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Department of Neurology and Psychiatry</orgName><orgName type="institution">University of Bari</orgName><address><settlement>Bari</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Graziella</forename><surname>Filippini</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Neuroepidemiology Unit</orgName><orgName type="institution">I.R.C.C.S. Foundation, Carlo Besta Neurological Institute</orgName><address><settlement>Milan</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Maria</forename><forename type="middle">Donata</forename><surname>Benedetti</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Department of Neurosciences</orgName><orgName type="institution">University Hospital</orgName><address><settlement>Verona</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Maura</forename><surname>Pugliatti</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">Department of Clinical and Experimental Medicine</orgName><orgName type="institution">University of Sassari</orgName><address><settlement>Sassari</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><persName><forename type="first">Carmela</forename><surname>Santuccio</surname></persName><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="institution">Italian Medicine Agency (AIFA)</orgName><address><settlement>Rome</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author role="corresp"><persName><forename type="first">Roberto</forename><surname>Raschetti</surname></persName><email>roberto.raschetti@iss.it</email><affiliation><orgName type="institution">The ITANG study group</orgName><orgName type="department">National Centre for Epidemiology, Surveillance and Health Promotion</orgName><orgName type="institution">National Institute of Health</orgName><address><settlement>Rome</settlement><country key="IT" xml:lang="en">ITALY</country></address></affiliation></author><author><orgName type="institution">The ITANG study group</orgName><persName><surname>The ITANG study group</surname></persName></author><idno type="istex">7645AB1CD10843E7F28770CD56AFD76FCB026A53</idno><idno type="ark">ark:/67375/VQC-SWXQST3K-W</idno><idno type="publisher-id">s10654-013-9797-8</idno><idno type="DOI">10.1007/s10654-013-9797-8</idno><idno type="article-id">9797</idno></analytic><monogr><title level="j" type="main">European Journal of Epidemiology</title><title level="j" type="abbrev">Eur J Epidemiol</title><idno type="journal-id">10654</idno><idno type="pISSN">0393-2990</idno><idno type="eISSN">1573-7284</idno><imprint><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer Netherlands</publisher><pubPlace>Dordrecht</pubPlace><date type="published" when="2013">2013</date><biblScope unit="vol" from="28" to="28">28</biblScope><biblScope unit="issue" from="5" to="5">5</biblScope><biblScope unit="page" from="433">433</biblScope><biblScope unit="page" to="444">444</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.48" when="2020-05-28"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en"><head>Abstract</head><p>Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.</p></abstract><textClass ana="subject"><keywords scheme="journal-subject"><list><item><label>SCH</label><term type="Primary">Medicine & Public Health</term></item><item><label>SCH63000</label><term type="Secondary" subtype="priority-1">Epidemiology</term></item><item><label>SCH27002</label><term type="Secondary" subtype="priority-2">Public Health</term></item><item><label>SCH33096</label><term type="Secondary" subtype="priority-3">Infectious Diseases</term></item><item><label>SCH33037</label><term type="Secondary" subtype="priority-4">Cardiology</term></item><item><label>SCH43008</label><term type="Secondary" subtype="priority-5">Oncology</term></item></list></keywords></textClass><textClass ana="keyword"><keywords xml:lang="en"><term>Influenza vaccination</term><term>Guillain-Barrè Syndrome</term><term>Case–control study</term><term>Self controlled case series</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2020-05-28" who="#istex" xml:id="pub2tei">formatting</change><change when="2013-03-15">Registration</change><change when="2012-08-08">Received</change><change when="2013-03-15">Accepted</change><change when="2013-03-31">ePublished</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer Netherlands</PublisherName><PublisherLocation>Dordrecht</PublisherLocation><PublisherImprintName>Springer</PublisherImprintName></PublisherInfo><Journal OutputMedium="All"><JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered"><JournalID>10654</JournalID><JournalPrintISSN>0393-2990</JournalPrintISSN><JournalElectronicISSN>1573-7284</JournalElectronicISSN><JournalTitle>European Journal of Epidemiology</JournalTitle><JournalSubTitle>Affiliated to the European Epidemiology Federation</JournalSubTitle><JournalAbbreviatedTitle>Eur J Epidemiol</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Code="SCH" Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Code="SCH63000" Priority="1" Type="Secondary">Epidemiology</JournalSubject><JournalSubject Code="SCH27002" Priority="2" Type="Secondary">Public Health</JournalSubject><JournalSubject Code="SCH33096" Priority="3" Type="Secondary">Infectious Diseases</JournalSubject><JournalSubject Code="SCH33037" Priority="4" Type="Secondary">Cardiology</JournalSubject><JournalSubject Code="SCH43008" Priority="5" Type="Secondary">Oncology</JournalSubject><SubjectCollection Code="SC11">Medicine</SubjectCollection></JournalSubjectGroup></JournalInfo><Volume OutputMedium="All"><VolumeInfo TocLevels="0" VolumeType="Regular"><VolumeIDStart>28</VolumeIDStart><VolumeIDEnd>28</VolumeIDEnd><VolumeIssueCount>12</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular" OutputMedium="All"><IssueInfo IssueType="Regular" TocLevels="0"><IssueIDStart>5</IssueIDStart><IssueIDEnd>5</IssueIDEnd><IssueArticleCount>10</IssueArticleCount><IssueHistory><OnlineDate><Year>2013</Year><Month>6</Month><Day>5</Day></OnlineDate><PrintDate><Year>2013</Year><Month>6</Month><Day>4</Day></PrintDate><CoverDate><Year>2013</Year><Month>5</Month></CoverDate><PricelistYear>2013</PricelistYear></IssueHistory><IssueCopyright><CopyrightHolderName>Springer Science+Business Media Dordrecht</CopyrightHolderName><CopyrightYear>2013</CopyrightYear></IssueCopyright></IssueInfo><Article ID="s10654-013-9797-8" OutputMedium="All"><ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"><ArticleID>9797</ArticleID><ArticleDOI>10.1007/s10654-013-9797-8</ArticleDOI><ArticleSequenceNumber>8</ArticleSequenceNumber><ArticleTitle Language="En" OutputMedium="All">Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</ArticleTitle><ArticleCategory>PHARMACO-EPIDEMIOLOGY</ArticleCategory><ArticleFirstPage>433</ArticleFirstPage><ArticleLastPage>444</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2013</Year><Month>3</Month><Day>15</Day></RegistrationDate><Received><Year>2012</Year><Month>8</Month><Day>8</Day></Received><Accepted><Year>2013</Year><Month>3</Month><Day>15</Day></Accepted><OnlineDate><Year>2013</Year><Month>3</Month><Day>31</Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName>The Author(s)</CopyrightHolderName><CopyrightYear>2013</CopyrightYear><License SubType="CC BY" Type="OpenAccess" Version="2.0"><SimplePara><Emphasis Type="Bold">Open Access</Emphasis>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</SimplePara></License></ArticleCopyright><ArticleGrants Type="OpenChoice"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="OpenAccess"></BodyPDFGrant><BodyHTMLGrant Grant="OpenAccess"></BodyHTMLGrant><BibliographyGrant Grant="OpenAccess"></BibliographyGrant><ESMGrant Grant="OpenAccess"></ESMGrant></ArticleGrants></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Francesca</GivenName><FamilyName>Galeotti</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Marco</GivenName><FamilyName>Massari</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff2"><AuthorName DisplayOrder="Western"><GivenName>Roberto</GivenName><FamilyName>D’Alessandro</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff3"><AuthorName DisplayOrder="Western"><GivenName>Ettore</GivenName><FamilyName>Beghi</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff4"><AuthorName DisplayOrder="Western"><GivenName>Adriano</GivenName><FamilyName>Chiò</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff5"><AuthorName DisplayOrder="Western"><GivenName>Giancarlo</GivenName><FamilyName>Logroscino</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff6"><AuthorName DisplayOrder="Western"><GivenName>Graziella</GivenName><FamilyName>Filippini</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff7"><AuthorName DisplayOrder="Western"><GivenName>Maria</GivenName><GivenName>Donata</GivenName><FamilyName>Benedetti</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff8"><AuthorName DisplayOrder="Western"><GivenName>Maura</GivenName><FamilyName>Pugliatti</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff9"><AuthorName DisplayOrder="Western"><GivenName>Carmela</GivenName><FamilyName>Santuccio</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Roberto</GivenName><FamilyName>Raschetti</FamilyName></AuthorName><Contact><Phone>+39-06-49904242</Phone><Fax>+39-06-49904248</Fax><Email>roberto.raschetti@iss.it</Email></Contact></Author><InstitutionalAuthor><InstitutionalAuthorName>The ITANG study group</InstitutionalAuthorName></InstitutionalAuthor><Affiliation ID="Aff1"><OrgDivision>National Centre for Epidemiology, Surveillance and Health Promotion</OrgDivision><OrgName>National Institute of Health</OrgName><OrgAddress><City>Rome</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff2"><OrgDivision>Neuroepidemiology Unit</OrgDivision><OrgName>I.R.C.C.S. Istituto delle Scienze Neurologiche</OrgName><OrgAddress><City>Bologna</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff3"><OrgDivision>Laboratory of Neurological Disorders</OrgDivision><OrgName>“Mario Negri” Institute for Pharmacological Research</OrgName><OrgAddress><City>Milan</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff4"><OrgDivision>Department of Neuroscience</OrgDivision><OrgName>University of Turin</OrgName><OrgAddress><City>Turin</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff5"><OrgDivision>Department of Neurology and Psychiatry</OrgDivision><OrgName>University of Bari</OrgName><OrgAddress><City>Bari</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff6"><OrgDivision>Neuroepidemiology Unit</OrgDivision><OrgName>I.R.C.C.S. Foundation, Carlo Besta Neurological Institute</OrgName><OrgAddress><City>Milan</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff7"><OrgDivision>Department of Neurosciences</OrgDivision><OrgName>University Hospital</OrgName><OrgAddress><City>Verona</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff8"><OrgDivision>Department of Clinical and Experimental Medicine</OrgDivision><OrgName>University of Sassari</OrgName><OrgAddress><City>Sassari</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation><Affiliation ID="Aff9"><OrgName>Italian Medicine Agency (AIFA)</OrgName><OrgAddress><City>Rome</City><Country Code="IT">Italy</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En" OutputMedium="All"><Heading>Abstract</Heading><Para>Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.</Para></Abstract><KeywordGroup Language="En" OutputMedium="All"><Heading>Keywords</Heading><Keyword>Influenza vaccination</Keyword><Keyword>Guillain-Barrè Syndrome</Keyword><Keyword>Case–control study</Keyword><Keyword>Self controlled case series</Keyword></KeywordGroup><ArticleNote Type="Misc"><SimplePara>ITAlian Network for the study of GBS study group is given in Appendix. F. Galeotti and M. Massari are currently employed at the Italian Medicine Agency (AIFA), Rome, Italy.</SimplePara></ArticleNote></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination</title></titleInfo><name type="corporate"><namePart>The ITANG study group</namePart></name><name type="personal"><namePart type="given">Francesca</namePart><namePart type="family">Galeotti</namePart><affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marco</namePart><namePart type="family">Massari</namePart><affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Roberto</namePart><namePart type="family">D’Alessandro</namePart><affiliation>Neuroepidemiology Unit, I.R.C.C.S. Istituto delle Scienze Neurologiche, Bologna, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ettore</namePart><namePart type="family">Beghi</namePart><affiliation>Laboratory of Neurological Disorders, “Mario Negri” Institute for Pharmacological Research, Milan, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Adriano</namePart><namePart type="family">Chiò</namePart><affiliation>Department of Neuroscience, University of Turin, Turin, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Giancarlo</namePart><namePart type="family">Logroscino</namePart><affiliation>Department of Neurology and Psychiatry, University of Bari, Bari, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Graziella</namePart><namePart type="family">Filippini</namePart><affiliation>Neuroepidemiology Unit, I.R.C.C.S. Foundation, Carlo Besta Neurological Institute, Milan, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Maria</namePart><namePart type="given">Donata</namePart><namePart type="family">Benedetti</namePart><affiliation>Department of Neurosciences, University Hospital, Verona, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Maura</namePart><namePart type="family">Pugliatti</namePart><affiliation>Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Carmela</namePart><namePart type="family">Santuccio</namePart><affiliation>Italian Medicine Agency (AIFA), Rome, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal" displayLabel="corresp"><namePart type="given">Roberto</namePart><namePart type="family">Raschetti</namePart><affiliation>National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy</affiliation><affiliation>E-mail: roberto.raschetti@iss.it</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="OriginalPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Springer Netherlands</publisher><place><placeTerm type="text">Dordrecht</placeTerm></place><dateCreated encoding="w3cdtf">2012-08-08</dateCreated><dateIssued encoding="w3cdtf">2013-05-01</dateIssued><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between influenza vaccination and GBS. The study included 176 GBS incident cases aged ≥18 years from 86 neurological centers. Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases. Each control was matched to a case by sex, age, Region and admission date. Two different analyses were conducted: a matched case–control analysis and a self-controlled case series analysis (SCCS). Case–control analysis included 140 cases matched to 308 controls. The adjusted matched odds ratio (OR) for GBS occurrence within 6 weeks after influenza vaccination was 3.8 (95 % CI: 1.3, 10.5). A much stronger association with gastrointestinal infections (OR = 23.8; 95 % CI 7.3, 77.6) and influenza-like illness or upper respiratory tract infections (OR = 11.5; 95 % CI 5.6, 23.5) was highlighted. The SCCS analysis included all 176 GBS cases. Influenza vaccination was associated with GBS, with a relative risk of 2.1 (95 % CI 1.1, 3.9). According to these results the attributable risk in adults ranges from two to five GBS cases per 1,000,000 vaccinations.</abstract><note>PHARMACO-EPIDEMIOLOGY</note><subject lang="en"><genre>Keywords</genre><topic>Influenza vaccination</topic><topic>Guillain-Barrè Syndrome</topic><topic>Case–control study</topic><topic>Self controlled case series</topic></subject><relatedItem type="host"><titleInfo><title>European Journal of Epidemiology</title><subTitle>Affiliated to the European Epidemiology Federation</subTitle></titleInfo><titleInfo type="abbreviated"><title>Eur J Epidemiol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>Springer</publisher><dateIssued encoding="w3cdtf">2013</dateIssued><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><subject><genre>Journal-Subject-Collection</genre><topic authority="SpringerSubjectCodes" authorityURI="SC11">Medicine</topic></subject><classification authority="Journal-SubjectCollection-Code">SC11</classification><subject><genre>Journal-Subject-Group</genre><topic authority="SpringerSubjectCodes" authorityURI="SCH">Medicine & Public Health</topic><topic authority="SpringerSubjectCodes" authorityURI="SCH63000">Epidemiology</topic><topic authority="SpringerSubjectCodes" authorityURI="SCH27002">Public Health</topic><topic authority="SpringerSubjectCodes" authorityURI="SCH33096">Infectious Diseases</topic><topic authority="SpringerSubjectCodes" authorityURI="SCH33037">Cardiology</topic><topic authority="SpringerSubjectCodes" authorityURI="SCH43008">Oncology</topic></subject><identifier type="ISSN">0393-2990</identifier><identifier type="eISSN">1573-7284</identifier><identifier type="JournalID">10654</identifier><identifier type="IssueArticleCount">10</identifier><identifier type="VolumeIssueCount">12</identifier><part><date>2013</date><detail type="volume"><number>28</number><caption>vol.</caption></detail><detail type="issue"><number>5</number><caption>no.</caption></detail><extent unit="pages"><start>433</start><end>444</end></extent></part><recordInfo><recordOrigin>Springer Science+Business Media Dordrecht, 2013</recordOrigin></recordInfo></relatedItem><identifier type="istex">7645AB1CD10843E7F28770CD56AFD76FCB026A53</identifier><identifier type="ark">ark:/67375/VQC-SWXQST3K-W</identifier><identifier type="DOI">10.1007/s10654-013-9797-8</identifier><identifier type="ArticleID">9797</identifier><identifier type="ArticleID">s10654-013-9797-8</identifier><accessCondition type="use and reproduction" contentType="copyright">The Author(s), 2013</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource><recordOrigin>Converted from (version 1.2.14) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2020-05-29</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-SWXQST3K-W/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001C28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:7645AB1CD10843E7F28770CD56AFD76FCB026A53
|texte= Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination
}}
| This area was generated with Dilib version V0.6.34. |  |